Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
InChiKey: NMDYYWFGPIMTKO-KLCPSUAYSA-N
1]octan-3-yl}-1
5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62
13(9):2771-2782
2018 Jan 15
Mutant IDH1-IN-2 ecyl sulfate D25 InChiKey: NMDYYWFGPIMTKO-KLCPSUAYSA-NMutant IDH1 IN 2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of in LS MS biochemical assay, IC50 of 16. 6 nM in Fluorescence biochemical assay. Target: Mutant IDH1Mutant IDH1 IN 2 has a neomorphic activity and in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell proliferation disorders, such as cancer. More bioactivity information in Patent WO
US$ 48.50
US$ 82.00
US$ 52.00
US$ 74.00
US$ 38.00
US$ 46.00